Acrylamide

Acrylamide

SCHEMBL8663429

C=CC(N)=O.Nc1c(I)cc(I)c(C(=O)O)c1I

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 2/20 0.37
CYP2C9 P11712 2/20 0.37
CHRM1 P11229 1/20 0.37
TBXA2R P21731 1/20 0.37
PDE4A P27815 1/20 0.37
ADRA1A P35348 1/20 0.37
CYP1A2 P05177 1/20 0.37
HIF1A Q16665 1/20 0.37
ALDH1A1 P00352 1/20 0.37
FGFR4 P22455 1/20 0.37
TPMT P51580 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394151 0.88 TSHR (0.46) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL124763 0.88 TSHR (0.46) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL6396616 0.86 TSHR (0.45) TSHRMAPK1LMNACYP2C9CHRM1
Butanedione SCHEMBL27926797 0.79 LMNA (0.44) TSHRMAPK1LMNACYP2C9CHRM1
Glutarate SCHEMBL11207827 0.77 TSHR (0.49) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL6012587 0.76 LMNA (0.40) TSHRMAPK1LMNACYP2C9CHRM1
SCHEMBL30956331 0.75 MAPK1 (0.42) TSHRMAPK1ALDH1A1TPMT
SCHEMBL29248751 0.75 MAPK1 (0.42) TSHRMAPK1ALDH1A1TPMT
SCHEMBL8663431 0.74 LMNA (0.33) LMNACYP2C9CHRM1TBXA2RPDE4A
SCHEMBL377395 0.73 MAPK1 (0.53) TSHRMAPK1LMNACYP2C9CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5780668-A A CURABLE MONOMER OF A (MONO-, DI- OR TRIACRYLOYLOXY-SUBSTITUTED ALKYLENEAMIDO OR OXYCARBONYL-) -TRIODOBENZENES; REPLACES FILLERS IN CROWNS, BRIDGES ETC.; UV RESISTANCE; STABILITY IVOCLAR AG (LI) 1998-07-14 US disclosed